Most Read Articles
Jairia Dela Cruz, 22 Apr 2020
A wristwatch-like device that monitors pulse, breathing and blood oxygen levels of the user allows physicians to provide care remotely both in hospital and nontraditional settings, and may help in the fight against the coronavirus disease 2019 (COVID-19) pandemic.
Roshini Claire Anthony, 27 May 2020

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates. 

Pank Jit Sin, 21 May 2020

Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.

Stephen Padilla, 28 May 2020
Herd immunity will not work in the novel coronavirus disease (COVID-19), according to an infectious disease expert who addressed over 3,600 primary care physicians (PCP) from Asia Pacific at the inaugural webcast of the MIMS COVID Conversations Series.

Bacterial infection more prevalent in febrile infants aged 61–90 days than in younger ones

05 Dec 2019

Febrile infants aged between 61 and 90 days appear to have a high prevalence of invasive bacterial infection (IBI), lending support to obtaining urine and blood tests in this population, suggests a recent study.

A total of 3,301 infants were included, among whom 605 (18.3 percent) had a serious bacterial infection (SBI; mainly urinary tract infection). Of those with SBI, 81 (2.5 percent) had IBI (bacteraemia, n=60; meningitis, n=12; sepsis, n=9).

SBI prevalence was 18.5 percent (95 percent confidence interval [CI], 16.4–20.7) among infants >60 days old as compared with 16.6 percent CI, 14.7–18.7) in those between 29 and 60 days and 21.5 percent (95 percent CI, 18.6–24.7) in those <28 days of age.

IBI prevalence was 1.1 percent (95 percent CI, 0.6–2.2) among infants >60 days old as compared with 2.3 percent (95 percent CI, 1.6–3.3; p<0.05) in those 29–60 days and 5.1 percent (95 percent CI, 3.7–7.0; p<0.05) in those <28 days of age. IBI prevalence in well-appearing infants aged >60 days was 1.0 percent (vs 4.5 percent in those <28 days old; p<0.01; and 2.0 percent in those 29–60 days old; p=0.06). Except for one, all infants aged <28 days were diagnosed with bacterial meningitis.

This prospective registry-based cohort study included all infants ≤90 days with fever without a source evaluated in a paediatric emergency department between 2003 and 2017. The prevalence of SBI and IBI was compared in febrile infants <60 days of age and those between 61 and 90 days. 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 22 Apr 2020
A wristwatch-like device that monitors pulse, breathing and blood oxygen levels of the user allows physicians to provide care remotely both in hospital and nontraditional settings, and may help in the fight against the coronavirus disease 2019 (COVID-19) pandemic.
Roshini Claire Anthony, 27 May 2020

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates. 

Pank Jit Sin, 21 May 2020

Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.

Stephen Padilla, 28 May 2020
Herd immunity will not work in the novel coronavirus disease (COVID-19), according to an infectious disease expert who addressed over 3,600 primary care physicians (PCP) from Asia Pacific at the inaugural webcast of the MIMS COVID Conversations Series.